de Andrade DCO - Search Results

1

Cognitive dysfunction and serum levels of brain-derived neurotrophic factor (BDNF) in primary anti-phospholipid syndrome (PAPS).

Rosa RF, Ugolini-Lopes MR, Gandara APR, Vendramini MBG, Campanholo KR, Dutra L, de Andrade DCO. Rosa RF, et al. Among authors: de andrade dco. Rheumatology (Oxford). 2021 Jan 5;60(1):179-187. doi: 10.1093/rheumatology/keaa252. Rheumatology (Oxford). 2021. PMID: 32613245

2

High frequency of osteoporosis and fractures in women with dermatomyositis/polymyositis.

de Andrade DC, de Magalhães Souza SC, de Carvalho JF, Takayama L, Borges CT, Aldrighi JM, Pereira RM. de Andrade DC, et al. Rheumatol Int. 2012 Jun;32(6):1549-53. doi: 10.1007/s00296-011-1821-2. Epub 2011 Feb 16. Rheumatol Int. 2012. PMID: 21327426

3

Enhanced type I interferon gene signature in primary antiphospholipid syndrome: Association with earlier disease onset and preeclampsia.

Ugolini-Lopes MR, Torrezan GT, Gândara APR, Olivieri EHR, Nascimento IS, Okazaki E, Bonfá E, Carraro DM, de Andrade DCO. Ugolini-Lopes MR, et al. Among authors: de andrade dco. Autoimmun Rev. 2019 Apr;18(4):393-398. doi: 10.1016/j.autrev.2018.11.004. Epub 2019 Feb 14. Autoimmun Rev. 2019. PMID: 30772492

4

Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study.

Nascimento IS, Radin M, Gândara APR, Sciascia S, de Andrade DCO. Nascimento IS, et al. Among authors: de andrade dco. Lupus. 2020 Jun;29(7):676-685. doi: 10.1177/0961203320916527. Epub 2020 Apr 11. Lupus. 2020. PMID: 32279584

5

Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases.

Tonacio AC, do Nascimento Pedrosa T, Borba EF, Aikawa NE, Pasoto SG, Filho JCRF, Sampaio Barros MM, Leon EP, Lombardi SCFS, Junior AM, Azevedo AS, Schwarcz WD, Fuller R, Yuki EFN, Ugolini Lopes MR, Rodrigues Pereira RM, Sampaio Barros PD, de Andrade DCO, de Medeiros-Ribeiro AC, de Moraes JCB, Shinjo SK, Miossi R, da Silva Duarte AJ, Lopes MH, Kallás EG, Almeida da Silva CA, Bonfá E. Tonacio AC, et al. Among authors: de andrade dco. PLoS Negl Trop Dis. 2021 Nov 29;15(11):e0010002. doi: 10.1371/journal.pntd.0010002. eCollection 2021 Nov. PLoS Negl Trop Dis. 2021. PMID: 34843469 Free PMC article. Clinical Trial.

6

Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry.

Balbi GGM, Ahmadzadeh Y, Tektonidou MG, Pengo V, Sciascia S, Ugarte A, Belmont HM, Lopez-Pedrera C, Fortin PR, Wahl D, Gerosa M, de Jesús GR, Ji L, Atsumi T, Efthymiou M, Branch DW, Nalli C, Rodriguez Almaraz E, Petri M, Cervera R, Knight JS, Artim-Esen B, Willis R, Bertolaccini ML, Cohen H, Roubey R, Erkan D, de Andrade DCO; for AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (APS ACTION). Balbi GGM, et al. Among authors: de andrade dco. Rheumatology (Oxford). 2024 Mar 1;63(3):772-779. doi: 10.1093/rheumatology/kead292. Rheumatology (Oxford). 2024. PMID: 37307082 Free PMC article.

7

ABO blood group in primary antiphospholipid syndrome: influence in the site of thrombosis?

Nascimento NM, Bydlowski SP, Soares RP, de Andrade DC, Bonfá E, Seguro LP, Borba EF. Nascimento NM, et al. J Thromb Thrombolysis. 2015 Oct;40(3):374-8. doi: 10.1007/s11239-015-1176-8. J Thromb Thrombolysis. 2015. PMID: 25638331 Clinical Trial.

8

Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS).

Balbi GGM, Pacheco MS, Monticielo OA, Funke A, Danowski A, Santiago MB, Staub HL, Rêgo J, de Andrade DCO. Balbi GGM, et al. Among authors: de andrade dco. Adv Rheumatol. 2020 May 27;60(1):29. doi: 10.1186/s42358-020-00125-9. Adv Rheumatol. 2020. PMID: 32460902 Review.

9

Controversies in the Management of Antiphospholipid Syndrome.

Porta SV, de Andrade DCO, Erkan D, Gómez-Puerta JA, Jara LJ, Alba Moreyra P, Pons-Estel GJ. Porta SV, et al. Among authors: de andrade dco. J Clin Rheumatol. 2023 Aug 1;29(5):e107-e112. doi: 10.1097/RHU.0000000000001961. J Clin Rheumatol. 2023. PMID: 37478021

10

Early subclinical macular disease in asymptomatic patients with primary antiphospholipid syndrome: A quantitative multimodal retinal evaluation.

Zacharias LC, Neto TDSR, Dias da Silva Neto E, Monteiro MLR, Balbi GGM, Signorelli F, Higashi AH, Bonfá E, de Andrade DCO. Zacharias LC, et al. Among authors: de andrade dco. Lupus. 2025 Jan;34(1):79-87. doi: 10.1177/09612033241307895. Epub 2024 Dec 10. Lupus. 2025. PMID: 39659040

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters